Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Low doses of pharmaceutical formulations loaded with UFMG-V4N2 immunogen induce the production of IgG anti-cocaine antibodies and provide evidence of cerebral protection in the preclinical model. Local targets link to admitted publications; unresolved targets remain external evidence.
Differences in mortality in a cohort of cocaine use disorder patients with concurrent alcohol or opiates disorder
10.1111/add.14165 · 2018 · External reference
The continuing search for an addiction vaccine
10.1016/j.vaccine.2019.06.074 · 2019 · External reference
Cocaine vaccines: antibody protection against relapse in a rat model
10.1073/pnas.97.11.6202 · 2000 · External reference
The GNE-KLH anti-cocaine vaccine protects dams and offspring from cocaine-induced effects during the prenatal and lactating periods
10.1038/s41380-021-01210-1 · 2021 · External reference
Hapten optimization for cocaine vaccine with improved cocaine recognition
10.1111/cbdd.12326 · 2014 · External reference
Novel cocaine vaccine linked to a disrupted adenovirus gene transfer vector blocks cocaine psychostimulant and reinforcing effects
10.1038/npp.2011.200 · 2012 · External reference
Development of vaccine formulations: past, present, and future
10.1007/s13346-021-00924-7 · 2021 · External reference
A guide to vaccinology: from basic principles to new developments
10.1038/s41577-020-00479-7 · 2021 · External reference
Calix [n] arene-based immunogens: a new non-proteic strategy for anti-cocaine vaccine
10.1016/j.jare.2021.09.003 · 2021 · External reference
Nanotechnology in adjuvants and vaccine development: what should we know?
10.2217/nnm-2021-0360 · 2021 · External reference
Nanoemulsion: an advanced mode of drug delivery system
10.1007/s13205-014-0214-0 · 2015 · External reference
Optimizing the utilization of aluminum adjuvants in vaccines: you might just get what you want
10.1038/s41541-018-0089-x · 2018 · External reference
Aluminum hydroxide nanoparticles show a stronger vaccine adjuvant activity than traditional aluminum hydroxide microparticles
10.1016/j.jconrel.2013.10.032 · 2014 · External reference
Unresolved reference
1994 · External reference
Unresolved reference
2009 · External reference
Characterization, optimization, and in vitro evaluation of Technetium-99m-labeled niosomes
10.2147/ijn.s184912 · 2019 · External reference
Impact of osmolality on burning sensations during and immediately after intramuscular injection of 0.5 ml of vaccine suspensions in healthy adults
10.1016/s0264-410x(01)00098-6 · 2001 · External reference
Correlation between pharmacological effects and plasma cocaine concentrations after smoked administration
10.1093/jat/26.7.382 · 2002 · External reference
The future of vaccines in the management of addictive disorders
10.1007/s11920-007-0049-z · 2007 · External reference
Fixed-interval schedule of cocaine reinforcement: effect of dose and infusion duration
10.1901/jeab.1973.20-119 · 1973 · External reference
Varying the rate of intravenous cocaine infusion influences the temporal dynamics of both drug and dopamine concentrations in the striatum
10.1111/ejn.13941 · 2019 · External reference
Stress-induced cocaine craving and hypothalamic-pituitary-adrenal responses are predictive of cocaine relapse outcomes
10.1001/archpsyc.63.3.324 · 2006 · External reference
Cue-induced cocaine craving enhances psychosocial stress and vice versa in chronic cocaine users
10.1038/s41398-022-02204-5 · 2022 · External reference
Red-green emitting and superparamagnetic nanomarkers containing Fe3O4 functionalized with calixarene and rare earth complexes
10.1021/ic5018856 · 2014 · External reference
Preparation, characterization of cellulose-grafted with calix[4]arene polymers for the adsorption of heavy metals and dichromate anions
10.1016/j.jhazmat.2007.02.057 · 2007 · External reference
Solid state characterization of commercial crystalline and amorphous atorvastatin calcium samples
10.1208/s12249-010-9419-7 · 2010 · External reference
Determination of stable Co-amorphous drug-drug ratios from the eutectic behavior of crystalline physical mixtures
10.3390/pharmaceutics11120628 · 2019 · External reference
Immobilization of α-amylase onto a calix [4] arene derivative: evaluation of its enzymatic activity
10.1016/j.bioorg.2015.04.007 · 2015 · External reference
Aqueous solubilization of furosemide by supramolecular complexation with 4-sulphonic calix[n]arenes
10.1211/0022357023439 · 2004 · External reference
Pharmaceutical development and manufacturing of a parenteral formulation of a novel antitumor agent, VNP40101M
10.1208/pt020314 · 2001 · External reference
Drug delivery strategies for poorly water-soluble drugs: the industrial perspective
10.1517/17425247.2011.614228 · 2011 · External reference
Insight into the cellular fate and toxicity of aluminium adjuvants used in clinically approved human vaccinations
10.1038/srep31578 · 2016 · External reference
Potentiation of the immune response to non-adsorbed antigens by aluminum-containing adjuvants
10.1016/j.vaccine.2006.09.039 · 2007 · External reference
Fluorescent nanodiamonds as a relevant tag for the assessment of alum adjuvant particle biodisposition
10.1186/s12916-015-0388-2 · 2015 · External reference
From stock bottle to vaccine: elucidating the particle size distributions of aluminum adjuvants using dynamic light scattering
2016 · External reference
Aluminum compounds used as adjuvants in vaccines
10.1023/a:1015994006859 · 1990 · External reference
Physicochemical characterization techniques for solid lipid nanoparticles: principles and limitations
10.3109/03639045.2014.909840 · 2014 · External reference
Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery
10.1208/s12249-010-9563-0 · 2011 · External reference
Factors affecting alum-protein interactions
10.1016/j.ijpharm.2014.03.015 · 2014 · External reference
Reprogramming the adjuvant properties of aluminum oxyhydroxide with nanoparticle technology
10.1038/s41541-018-0094-0 · 2019 · External reference
Osmolalities of propylene glycol-containing drug formulations for parenteral use. Should propylene glycol be used as a solvent?
10.1213/00000539-199209000-00020 · 1992 · External reference
Osmolalities of commercially supplied drugs often used in anesthesia
10.1213/00000539-198704000-00016 · 1987 · External reference
Effects of solution conditions and surface chemistry on the adsorption of three recombinant botulinum neurotoxin antigens to aluminum salt adjuvants
10.1002/jps.20880 · 2007 · External reference
The impact of size on particulate vaccine adjuvants
10.2217/nnm.14.193 · 2014 · External reference
Role of aluminum-containing adjuvants in antigen internalization by dendritic cells in vitro
10.1016/j.vaccine.2004.07.050 · 2005 · External reference
Effects of microparticle size and Fc density on macrophage phagocytosis
10.1371/journal.pone.0060989 · 2013 · External reference
Role of particle size in phagocytosis of polymeric microspheres
10.1007/s11095-008-9562-y · 2008 · External reference
Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model
10.1016/j.ijpharm.2005.03.035 · 2005 · External reference
Adjuvants: classification, modus operandi, and licensing
2016 · External reference
Keyhole limpet haemocyanin - a model antigen for human immunotoxicological studies
10.1111/bcp.12422 · 2014 · External reference
Immunological responses to nasal delivery of free and encapsulated tetanus toxoid: studies on the effect of vehicle volume
10.1016/s0378-5173(99)00239-2 · 1999 · External reference
TOR in the immune system
10.1016/j.ceb.2011.08.006 · 2011 · External reference
The concept of hormesis in cancer therapy - is less more?
2015 · External reference
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
10.1016/s0140-6736(20)32661-1 · 2021 · External reference
Immunological evaluation and comparison of different EV71 vaccine candidates
10.1155/2012/831282 · 2012 · External reference
Cocaine vaccine for the treatment of cocaine dependence in methadone-maintained patients A randomized, double-blind, placebo-controlled efficacy trial
10.1001/archgenpsychiatry.2009.128 · 2009 · External reference
Functionalized calix [4] arenes as potential therapeutic agents
10.1111/cbdd.12818 · 2017 · External reference
Synthetic vaccine characterization and design
10.1166/jbns.2018.1498 · 2018 · External reference
